Kinross, PetePetersen, AndreasSkov, RobertVan Hauwermeiren, EvelynPantosti, AnnalisaLaurent, FrédéricVoss, AndreasKluytmans, JanStruelens, Marc J.Heuer, OleMonnet, Dominique L.The European human LA-MRSA study group2018-03-072018-03-072017-11Euro Surveill. 2017 Nov;22(44):pii=16-00696. doi: 10.2807/1560-7917.ES.2017.22.44.16-00696.1560-791http://hdl.handle.net/10400.18/5354European human LA-MRSA study group: Portugal – Manuela Caniça, Vera Manageiro (Department of Infectious Diseases, National Institute of Health Doutor Ricardo Jorge, Lisbon)Currently, surveillance of livestock-associated meticillin-resistantStaphylococcus aureus(LA-MRSA) in humans in Europe is not systematic but mainly event-based. In September 2014, the European Centre for Disease Prevention and Control (ECDC) initiated a questionnaire to collect data on the number of LA-MRSA from human samples (one isolate per patient) from national/regional reference laboratories in European Union/European Economic Area (EU/EEA) countries in 2013. Identification of LA-MRSA as clonal complex (CC) 398 by multilocus sequence typing (MLST) was preferred, although surrogate methods such asspa-typing were also accepted. The questionnaire was returned by 28 laboratories in 27 EU/EEA countries. Overall, LA-MRSA represented 3.9% of 13,756 typed MRSA human isolates, but it represented ≥ 10% in five countries (Belgium, Denmark, Spain, the Netherlands and Slovenia). Seven of the reference laboratories did not type MRSA isolates in 2013. To monitor the dispersion of LA-MRSA and facilitate targeted control measures, we advocate periodic systematic surveys or integrated multi-sectorial surveillance.engMeticillin-Resistant Staphylococcus aureusHumansEuropeCross-Sectional StudiesAntibiotic ResistanceResistência aos Antimicrobianosjournal article10.2807/1560-7917.ES.2017.22.44.16-00696